April 29, 2024
Spectrum News highlighted the work of UC student Mallika Desai and the student group Parkinson's Together that takes a multidisciplinary approach to meeting the needs of patients with Parkinson's disease in their community.
April 29, 2024
The University of Cincinnati recognizes undergraduate student researchers for outstanding achievement in the sciences and humanities.
April 29, 2024
A $13.5 million gift from the estate of Hugh H. Hoffman, MBA ’63, will revolutionize research and patient care related to amyotrophic lateral sclerosis (ALS) at the ALS Multidisciplinary Clinic at the University of Cincinnati Gardner Neuroscience Institute.
April 29, 2024
Spectrum News highlighted the work of UC student Mallika Desai and the student group Parkinson's Together that takes a multidisciplinary approach to meeting the needs of patients with Parkinson's disease in their community.
April 29, 2024
The University of Cincinnati recognizes undergraduate student researchers for outstanding achievement in the sciences and humanities.
April 29, 2024
A $13.5 million gift from the estate of Hugh H. Hoffman, MBA ’63, will revolutionize research and patient care related to amyotrophic lateral sclerosis (ALS) at the ALS Multidisciplinary Clinic at the University of Cincinnati Gardner Neuroscience Institute.
April 23, 2024
Local 12 spoke with patient Shane Shapiro and the University of Cincinnati's Laura Ngwenya about the importance of wearing a helmet following Shapiro's traumatic brain injury and recovery.
April 22, 2024
Dr. Liran Oren is leading a research team at the University of Cincinnati developing a VortexPAP machine that takes advantage of vortex airflow technology. A preliminary clinical study with current CPAP users demonstrated that the VortexPAP can deliver the pressure levels that are used in the subjects’ CPAP therapy, but the mask is more comfortable to wear. It has a minimalistic design that is less intrusive and barely touches the patient’s face.
Event: May 3, 2024 12:00 PM
The University of Cincinnati Cancer Center is hosting a special kickoff event on Friday, May 3 from 12-1 p.m. in Kresge Auditorium to celebrate the opening of registration for Ride Cincinnati 2024, an annual fundraiser for local cancer research.
April 17, 2024
Medscape highlighted University of Cincinnati research published in JAMA Dermatology that found skin adverse events were rare following immunotherapy treatments for certain skin cancers.
April 17, 2024
Researchers at the University of Cincinnati are developing a VortexPAP machine that takes advantage of vortex airflow technology. A preliminary clinical study with current CPAP users demonstrated that the VortexPAP can deliver the pressure levels that are used in the subjects’ CPAP therapy, but the mask is more comfortable to wear. It has a minimalistic design that is less intrusive and barely touches the patient’s face.
April 15, 2024
University of Cincinnati student-led nonprofit organization Parkinson's Together takes a multidisciplinary approach to meeting the needs of patients with Parkinson's disease in their community. Now it's setting a model for student organizations across the country.
April 15, 2024
The University of Cincinnati's Carla Justiniano spoke with Healthline about colorectal cancer in an article about a woman diagnosed with cancer when she was seven months pregnant.
April 12, 2024
University of Cincinnati researchers will present abstracts at the American Academy of Neurology annual meeting 2024, April 13-18 in Denver, Colorado.
April 11, 2024
The University of Cincinnati Cancer Center is one of 25 sites across the country hosting the SHIP trial testing whether samples self-collected by patients for HPV testing are as accurate and effective as clinic-collected samples.
April 10, 2024
The University of Cincinnati's Richard Becker commented to MedCentral on a recent study that found people who limit their eating to an 8-hour period each day had a 91% greater risk of cardiovascular death than those who ate during a window of 12 to 16 hours.
April 4, 2024
Clinical research conducted at the University of Cincinnati College of Medicine and UC Health played a role in the U.S. Food and Drug Administration's March 26 approval of WINREVAIR™ (sotatercept-csrk) for the treatment of pulmonary arterial hypertension (PAH) in adults.
April 4, 2024
The University of Cincinnati's Shimul Shah was featured in the New York Times and Boston Globe discussing how a new technique of keeping donation organs alive outside the body is revolutionizing organ transplantation.